Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Kraeber (UK) Ltd

The family owned business, Kraeber & Co GmbH, is an independent, technology based enterprise which was founded on the 1st January 1980 in Hamburg. Hanseatic tradition together with courageous entrepreneurship characterize our company. We are committed to open and global competition which we stand up with our service capabilities. Our emphasis is the development, production, marketing and sales of active pharmaceutical ingredients (APIs) of the highest purity. Kraeber has evolved into a niche marketer and supplier. By continously innovating productions, we became the quality market leader in Europe and in other parts of the world for many of our products.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Kraeber (UK) Ltd
16 The Street, Saxon Street, Newmarket, Suffolk, CB8 9RU, United Kingdom
+44 (0)1638 731 297
Contact Kraeber (UK) Ltd
Website

 Latest Content from PMHub 

NHS primary care panel – the GP Contract and Operational Planning Guidance – Live Webinar

Press Releases | May 7, 2024 | Petauri Evidence

What can we expect to see in primary care in the NHS given recent policy announcements and ongoing uncertainty? What does the new GP Contract tell us about the future...

Free Live Webinar – Uniting Communities for Rare Disease Clinical Trial Success

Press Releases | May 3, 2024 | Innovative Trials

Join this live webinar focusing on patient recruitment and retention in rare disease trials.

Navigating the rapidly changing oncology treatment landscape: how digital tools can help

White Papers and Resources | May 2, 2024 | Impetus Digital

With rapid growth comes growing pains...

TRANSFORMING CME IMPACT: MEDSCAPE’S GAME-CHANGING APPROACH

Press Releases | May 2, 2024 | Medscape Education

It’s time for the CME industry to evolve. During recent years, access to data, modern technologies, and methodologies have allowed for deeper analysis of data and a better understanding of...

Hope in cancer therapy

Press Releases | May 1, 2024 | Springer Nature

The future looks hopeful as second-generation radiopharmaceuticals venture into uncharted territories.

Health awareness days in May

Press Releases | May 1, 2024 | Springer Nature

Are you marketing to clinical audiences around upcoming health awareness days?

Why Women in Medicine Should Embrace Social Media

Press Releases | May 1, 2024 | Medscape Education

Of course social media has its downside. But online platforms are a powerful tool for women in medicine in terms of forming communities, fighting misinformation, amplifying one another, and galvanizing...

Exceptional Impact Presented at ECCMID 2024

Press Releases | April 30, 2024 | Medscape Education

The ECCMID conference in Barcelona, Spain marked the start of Medscape’s publication season in Europe. With three posters being presented at the conference, Medscape shared highlights from the powerful impact...

The role of economic evaluation in US healthcare

White Papers and Resources | April 30, 2024 | Petauri Evidence

Hannah Palin (Director – Market Access) and Calum Jones (Associate Director – Health Economics) explore the landscape for economic evaluation in the US. They highlight important considerations for companies seeking...

How to successfully manage change and enable digital transformation within pharma

Press Releases | April 30, 2024 | Graphite Digital

Change is an essential aspect of any business, and learning to manage it effectively will be key for long-term success. Getting your team on board with change and digital transformation...